<DOC>
	<DOCNO>NCT00202007</DOCNO>
	<brief_summary>This study design subject relevant SFDA regulation clinical trial . Patients screen inclusion study initial visit ( 240 patient recruit ) undergo minimum 3-7 day ’ placebo washout period ( placebo wash eliminate effect prior antipsychotic medication tablet without active ingredient ) ( patient without prior antipsychotic medication exempt washout phase ) . After screen washout period , eligible patient randomly assign two treatment group , Aripiprazole Risperidone , 6 week ’ treatment . Patients hospitalize entire duration study . Patients ’ condition assess weekly .</brief_summary>
	<brief_title>Efficacy Safety Study Aripiprazole Treat Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Inclusion criterion screen 1 . Schizophrenia Acute schizophrenialike psychotic disorder ( ICD 10 ) 2 . PANSS total less 60 3 . Age : 1865 ; male female 4 . Informed consent legal guardian patient Inclusion criterion washout 1.PANSS total less 60 2.37days washout placebo require discontinuation oral antipsychotic ; No washout need patient never take antipsychotic ; In case patient ’ condition deem clinically deteriorate immediate treatment need , patient le 3 day ’ placebo washout could randomize notify sponsor 3.No serious function impairment heart , liver kidney . For screen 1 . Tendency history suicide 2 . Patients extreme agitation , violent attack behavior towards people hardly comply treatment 3 . Diagnosis mental disease besides Schizophrenia 4 . Diabetes serious unstable disease follow neurological disease , migraine , epilepsy , Parkinson ’ disease , Alzheimer ’ disease , multiple sclerosis , stroke TIA etc 5 . Patients take Fluoxetine past 1month screen 6 . Patients participate clinical trial past 1month screen 7 . History alcohol drug abuse dependence 8 . Pregnancy breastfeed 9 . Patients gastrointestinal operation could affect drug absorption . 10 . Allergy Risperidone Aripiprazole hypersensitiveness drug 11 . Patients discontinue longacting antipsychotic less one treatment cycle screen 12 . Refractory schizophrenia patient respond treatment two different type antipsychotic adequate dose course , patient respond Clozapine 13 . Patients Electroconvulsive Therapy ( ECT ) past 6 month After washout 1 . Diagnosis mental disease besides schizophrenia washout period 2 . Significant abnormal ECG laboratory examination result ( ALT , AST &gt; 1.5 time higher limit normal range ) , suitable enrol base investigator ’ discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Aripiprazole</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Risperidone</keyword>
</DOC>